ArticleMolecular cancer2025

Loss of TACC2 impairs chemokine CCL3 and CCL4 expression and reduces response to anti-PD-1 therapy in soft tissue sarcoma.

Jing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.